Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by amorakon Sep 28, 2011 11:28am

253 Views

Post# 19093163

RE: RE: RE: RE: RE: Amorak

I figured you'd ignore the questions, viking. LOL.
.
For those of you out there who might actually suffer from bipolar disorder, rest assured that unlike, viking, I would never use the term as a slur or as an accusation of having a character flaw. As I understand it, it is a nasty but generally treatable disorder. Viking's constant haranguing about "off your meds" and other such terms fully indicate all we need to know about his character.
.

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”